Dow Down 0.22% Nasdaq Up 0.14%

Synta Pharmaceuticals Corp. (SNTA)

-NasdaqGM
4.00 Up 0.03(0.76%) 4:00PM EDT
|After Hours : 4.00 0.00 (0.00%) 4:27PM EDT
Prev Close:3.97
Open:3.96
Bid:3.88 x 100
Ask:4.28 x 2000
1y Target Est:12.50
Beta:1.62
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:3.90 - 4.05
52wk Range:3.70 - 7.30
Volume:1,111,587
Avg Vol (3m):1,589,090
Market Cap:417.48M
P/E (ttm):N/A
EPS (ttm):-1.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SNTA

Comparison

Symbol% ChgMkt Cap
SNTAUp 0.76%417.48M
INFI 0.00%531.53M
NVS 0.00%215.81B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.02
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback